Market Overview

UPDATE: Bank of America Downgrades KEMET; Lowers PO

Related KEM
Lightning Round: Jim Cramer Advises His Viewers On Teva, Snap And More
Jim Cramer Shares His Thoughts On Deutsche Bank AG, Nucor And More
Don't Buy Snap - Cramer's Lightning Round (12/13/17) (Seeking Alpha)

According to a research report published this morning, Bank of America has downgraded KEMET (NYSE: KEM) from Buy to Underperform, and lowered PO from $12 to $8.

In the report, Bank of America commented, "We are downgrading shares of Kemet to Underperform from Buy given our view that the road to improvement in earnings will be a long one. We view primary headwinds as (1) slow recovery in Film and Electrolytic (F&E) margins from an unexpected breakeven gross margin in the latest reported quarter, (2) execution risk associated with multiple significant undertakings (restructuring, integration of Niotan, pending stake in NEC-Tokin), (3) increased interest expense from recently issued debt to fund the M&A, and (4) an uncertain macroeconomic environment."

KEMET closed yesterday at $7.52.

Latest Ratings for KEM

May 2016B. RileyInitiates Coverage onBuy
Nov 2013Deutsche BankMaintainsHold
Feb 2013Deutsche BankAssumesHold

View More Analyst Ratings for KEM
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Downgrades Price Target Analyst Ratings


Related Articles (KEM)

View Comments and Join the Discussion!